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Leptin, an adipocyte-derived hormone, acts on hy-
pothalamic neurons located in the arcuate nucleus
(ARC)of thehypothalamus to regulateenergyhomeo-
stasis. One of the leptin-regulated neuronal subtypes
in the ARC are agouti-related peptide (AgRP)-ex-
pressing neurons,whichare involved in the regulation
of food intake and aredirectly inhibited by leptin. Lep-
tin activates the signal transducer and activator of
transcription 3 (Stat3), but the role of Stat3 in the reg-
ulationofAgRPneurons is unclear. Hereweshow that
mice expressing a constitutively active version of
Stat3 selectively in AgRPneurons are lean and exhibit
relative resistance to diet-induced obesity. Surpris-
ingly, this phenotype arises from increased locomo-
tor activity in the presence of unaltered AgRP expres-
sion. These data demonstrate that Stat3-dependent
signaling in AgRP neurons in the ARC controls loco-
motor activity independently of AgRP regulation.
INTRODUCTION
Energy homeostasis is controlled in part by neurons located in
the arcuate nucleus (ARC) of the hypothalamus, which sense
and integrate signals they receive following changes in periph-
eral energy stores. One of these homeostatic signals is leptin,
which is secreted from adipose tissue and signals to hypotha-
lamic neurons involved in energy homeostasis. At least two
distinct populations of neurons within the ARC express the leptin
receptor (Cheung et al., 1997;Wilson et al., 1999) and are directly
regulated by leptin. While the orexigenic agouti-related peptide
(AgRP)/neuropeptide Y (NPY)-producing neurons are directly
inhibited by leptin (Elias et al., 1999; van den Top et al., 2004),
the anorexigenic pro-opiomelanocortin (POMC) neurons are
activated (Cowley et al., 2001; Elias et al., 1999). Consistently,
leptin-deficient ob/ob mice exhibit elevated levels of AgRP
mRNA and reduced levels of POMCmRNA (Mizuno and Mobbs,
1999; Schwartz et al., 1997; Shutter et al., 1997). Ablation of
POMC neurons, loss of POMC-derived transmitters, or lack of
excitatory leptin signaling in POMC cells results in obesity (Balth-236 Cell Metabolism 7, 236–248, March 2008 ª2008 Elsevier Inc.asar et al., 2004; Gropp et al., 2005; Yaswen et al., 1999), while
ablation of AgRP neurons and loss of AgRP lead to leanness
(Bewick et al., 2005; Gropp et al., 2005; Luquet et al., 2005).
More recently, we have demonstrated that insulin action in these
AgRP cells also controls hepatic gluconeogenesis (Konner et al.,
2007). These experiments underline the importance of AgRP and
POMC neuron regulation in the control of energy and glucose
homeostasis.
A key pathway downstream of the leptin receptor involves the
activation of the transcription factor signal transducer and acti-
vator of transcription 3 (Stat3) (Banks et al., 2000; Bjorbaek
et al., 1997), which dimerizes upon tyrosine phosphorylation
and translocates to the nucleus to bind to specific DNA elements
(Darnell et al., 1994; Leaman et al., 1996; Schindler and Darnell,
1995). Peripheral administration of leptin leads to rapid accumu-
lation of phosphorylated Stat3 in neurons of the hypothalamus
(Munzberg et al., 2003; Vaisse et al., 1996). Various mouse
models with neuronal deletion of Stat3 demonstrate an impor-
tant role of Stat3 in energy homeostasis. Panneuronal Stat3
knockout mice (Gao et al., 2004) and mice with mutated leptin
receptors that do not bind Stat3 (Bates et al., 2003) are hyper-
phagic, obese, and diabetic with reduced energy expenditure
and exhibit elevated levels of AgRP mRNA. However, the exact
molecular mechanism by which leptin inhibits AgRP expression
is still unclear.
Interestingly, several observations indicate that inhibition of
AgRP expression is independent of Stat3, although consensus
sites for Stat3 exist in the 50 region of the AgRP gene (Brown
et al., 2001) and overexpression of Stat3 causes inhibition of
AgRP transcription in reporter gene assays (Kitamura et al.,
2006). On the other hand, it has been shown that leptin requires
intact PI3 kinase signaling for inhibition of AgRPexpression (Mor-
rison et al., 2005) and that activation of Stat3 by leptin is not re-
quired for the regulation of AgRP neurons (Morrison et al., 2005;
Munzberg et al., 2007). Importantly, mice lacking Stat3 in AgRP
neurons exhibit normal levels ofAgRPmRNA (Kaelin et al., 2006).
Besides regulating food intake, leptin also regulates energy
expenditure and locomotor activity, since ob/obmice are hypo-
active and leptin treatment normalizes this defect in locomotor
activity (Pelleymounter et al., 1995; Plum et al., 2007). Surpris-
ingly, a recent study has implicated leptin action in the ARC in
the regulation of locomotor activity, since selective unilateral res-
toration of leptin signaling in the ARC of leptin receptor-deficient
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also normalizes locomotor activity (Coppari et al., 2005). Never-
theless, the exact neuronal population in the ARC responsible for
leptin-evoked locomotor activity has not been identified, and the
molecular mechanisms involved remain unknown.
To directly address the role of Stat3 signaling in AgRP-ex-
pressing neurons of the ARC, we have generated mice express-
ing a constitutively active version of Stat3 selectively in AgRP
neurons upon Cre-mediated recombination. These mice are
lean, aphenotype that surprisingly arises from increased locomo-
tor activity in the absence of reduced food intake and in the pres-
ence of unaltered AgRP expression. These experiments clearly
demonstrate that Stat3-dependent signaling in AgRP neurons
controls locomotor activity independently of AgRP regulation.
RESULTS
Generation of AgRP Neuron-Specific Stat3-C Mice
To investigate the role of Stat3-dependent signaling in AgRP-ex-
pressing neurons, we aimed to express a constitutively active
version of Stat3 specifically in this cell type. Therefore, we
crossed mice carrying a transgene encoding a constitutively
active form of the Stat3 protein (Stat3-C) including an upstream
loxP-flanked stop sequence in the ubiquitously expressed
Rosa26 locus (Casola et al., 2006) (Figure 1A) with mice express-
ing the Cre recombinase under control of the AgRP promoter
(Kaelin et al., 2004). In the Stat3-C protein, dimerization of
Stat3 is allowed by formation of disulfide bonds between two
substituted cysteines, leading to activation independent of sig-
nal-dependent tyrosine phosphorylation (Bromberg et al., 1999).
To confirm the specificity of transgene expression, we isolated
total RNA from a variety of tissues of control (Stat3-C+/) and
Stat3-CAgRP (Stat3-C+/AgRPCre) mice and determined the
expression of Stat3-C, endogenous Stat3, and GAPDH by
RT-PCR. Since AgRP is selectively expressed in neurons of the
ARC of the hypothalamus, Cre-dependent Stat3-C transgene
expression in Stat3-CAgRP mice should be detectable only in
the hypothalamus. Indeed, RT-PCR with transgene-specific
primers detected Stat3-C expression only in the hypothalamus,
and not in other brain regions or peripheral organs isolated from
Stat3-CAgRP mice. However, expression of endogenous Stat3
was detected to a similar extent in all tissues analyzed from
control and Stat3-CAgRP mice (Figure 1B).
Next, we analyzedwhether expression of overall hypothalamic
Stat3 was increased in Stat3-CAgRP mice using primers re-
cognizing both endogenous and transgenic Stat3 mRNA. In-
deed, hypothalamic Stat3 expression was 40%–70% higher in
Stat3-CAgRP animals compared to controls (Figure 1C).
To investigate whether the mutant Stat3-C acts as a constitu-
tively active DNA-binding transcription factor, we directly as-
sessed DNA-binding capacity of the transgenically expressed
Stat3-C. To this end, we first activated transcription of the trans-
gene in homologous recombinant embryonic stem (ES) cells
carrying the Rosa26-Stat3-C transgene. Cells were either left
untreated or treated with cell-permeable recombinant Cre pro-
tein. Subsequent electrophoretic mobility shift assays revealed
Stat3 binding to the consensus oligonucleotide probe in control
cells after treatment with leukemia inhibitory factor (LIF), but not
in the absence of LIF (data not shown). By contrast, ES cellsexpressing Stat3-C exhibited high Stat3 binding activity even in
the absence of LIF (data not shown).
To analyze the cell-type-specific restriction of Stat3-C expres-
sion further, Cre-mediated recombination was verified by cross-
ing AgRPCre mice with a reporter mouse strain in which tran-
scription of the b-galactosidase gene (LacZ) under control
of the Rosa26 promoter is prevented by a floxed hygromycin
resistance gene (RosaArte1) (Seibler et al., 2003). In this reporter
mouse strain (AgRPCre-LacZ), we observed a b-galactosidase
expression pattern reflecting the described expression of en-
dogenously expressed AgRP (Figure 1D), consistent with the
previously demonstrated colocalization of endogenous AgRP
and Cre recombinase activity in this line of Cre-transgenic
mice (Kaelin et al., 2006; Kaelin et al., 2004).
To further confirm the expression of the transgene selectively
in AgRP/NPY neurons, we performed combined NPY in situ
hybridization and Stat3 immunohistochemistry on hypothalamic
sections from fasted control and Stat3-CAgRP mice. In fasted
control animals, Stat3 expression was predominantly located
in the cytoplasm of NPY neurons. In contrast, Stat3 was also lo-
cated in the nuclei of NPY neurons of transgenicmice. Moreover,
the amount of Stat3 in NPY neurons of Stat3-CAgRP mice ap-
peared to be higher than in those of control animals (Figure 1E).
We next investigated whether the increase in Stat3 expression
resulted in elevated expression of the Stat3 target gene suppres-
sor of cytokine signaling 3 (Socs3). In fact, hypothalamic Socs3
mRNA expression in Stat3-CAgRP mice appeared to be 80%–
150% higher than in control animals, although this difference
did not reach statistical significance (Figure 1F).
Taken together, these data demonstrate that the transgenic
approach indeed results in AgRP neuron-restricted activation
of Stat3-C transcription and that this leads to enhanced basal
Stat3 binding activity in the hypothalamus of these mice, inde-
pendent of leptin stimulation.
As Stat3 has been described as exhibiting oncogenic potential
(Bromberg et al., 1999), we analyzed the morphology of NPY-
positive AgRP neurons from control and Stat3-CAgRP mice. We
first determined the size of NPY-positive neurons, but we could
not detect any difference between the neurons of control and
Stat3-CAgRP animals (Figure 1G). Furthermore, we injected con-
trol and Stat3-CAgRP mice intracerebroventricularly with bromo-
deoxyuridine (BrdU). Combined NPY in situ hybridization and
BrdU immunohistochemistry of hypothalamic sections revealed
only a few BrdU-positive cells in both control and transgenic
animals, and no BrdU incorporation into the DNA of NPY-posi-
tive neurons was detectable (see Figure S1 available online).
Thus, expression of Stat3-C in AgRP neurons does not appear
to affect neuron size or induce proliferation/transformation of
these neurons in Stat3-CAgRP mice.
Leanness in Stat3-CAgRP Mice
To investigate the impact of constitutively active Stat3 signaling
in AgRP neurons on the regulation of energy homeostasis, we
first monitored body weight of female and male control and
Stat3-CAgRP mice from weaning until 20 weeks of age under nor-
mal chow diet (NCD) and high-fat diet (HFD) conditions. Under
NCD conditions, both female and male Stat3-CAgRP mice ex-
hibited an approximately 10% reduction in body weight com-
pared to control mice (Figures 2A and 2B). This difference wasCell Metabolism 7, 236–248, March 2008 ª2008 Elsevier Inc. 237
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Stat3 Activation in AgRP NeuronsFigure 1. AgRP Neuron-Restricted Expression of a Constitutively Active Stat3 Transgene
(A) Map of the Stat3-C transgene for Cre-mediated conditional expression from theRosa26 locus. SA, adenoviral splice acceptor; filled triangles, loxP sites; NeoR,
neomycin resistance gene driven by the pGK promoter; WSS, Westphal stop sequence; Stat3-C, constitutively active form of Stat3; closed ellipses, FRT sites;
IRES, internal ribosome entry site; GFP, GFP gene. In this configuration, Cre-mediated recombination removes the loxP-flanked NeoR and Westphal stop
sequence only in cell types expressing Cre, thus allowing transcription of the bicistronic Stat3-C GFP mRNA.
(B) Expression of Stat3-C, endogenous Stat3, and GAPDH in different tissues of control and Stat3-CAgRP mice as determined by RT-PCR. WAT, white adipose
tissue; BAT, brown adipose tissue.
(C) Hypothalamic expression of Stat3 under fasted conditions in control (black bars) and Stat3-CAgRP (white bars) mice on a normal chow diet (NCD) (n = 7 per
genotype).
(D) Immunohistochemistry for b-galactosidase (b-gal) in brains of double-heterozygous reporter mice (AgRPCre-LacZ) at 10 weeks of age. Blue (DAPI), DNA;
green (b-gal), AgRP neurons. Scale bar = 200 mm (1003 magnification).
(E) Combined NPY in situ hybridization and Stat3 immunohistochemistry of hypothalamic sections from fasted control and Stat3-CAgRP mice at 12 weeks of age.
In control animals, Stat3 is mainly located in the cytoplasm of NPY neurons, whereas expression of the transgene leads to high Stat3 accumulation in the nuclei of
NPY neurons in Stat3-CAgRP mice. Scale bar = 200 mm (1003 magnification).
(F) Hypothalamic expression of Socs3 under fasted conditions in control (black bars) and Stat3-CAgRP (white bars) mice on NCD (n = 7 per genotype).
(G) Mean NPY neuron size in control and Stat3-CAgRP mice at 12 weeks of agemeasured on hypothalamic sections stained for NPY (n = 3mice per genotype, 80–
120 neurons per mouse).
All displayed values are means ± SEM. *p% 0.05, **p% 0.01, ***p% 0.001 versus control.more pronounced under HFD conditions, under which Stat3-
CAgRP mice gained 15%–20% less body weight until the age of
20 weeks. This reduction in body weight was similar in female
and male Stat3-CAgRP mice (Figures 2A and 2B).238 Cell Metabolism 7, 236–248, March 2008 ª2008 Elsevier Inc.To investigatewhether the reducedbodyweight inStat3-CAgRP
mice resulted from a decrease in fat mass, we examined the
amount of epigonadal fat in female and male control and Stat3-
CAgRP mice under both NCD and HFD conditions. Consistent
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displayed significantly reduced epigonadal fat-pad mass at the
age of 20 weeks compared to controls (Figures 2C and 2D).
The difference in fat-pad mass of Stat3-CAgRP and control mice
increased upon HFD, in that NCD-fed Stat3-CAgRP mice dis-
played a 30% reduction in epigonadal fat-pad weight and HFD-
fed mice showed a 40%–60% reduction (Figures 2C and 2D).
To further confirm reduced adiposity in Stat3-CAgRP mice, we
also determined body fat content of 20-week-old mice by in vivo
magnetic resonance spectrometry. Mean body fat content was
20%–30% decreased in Stat3-CAgRP mice under NCD and
HFD conditions (Figure 2E). Leanness was accompanied by re-
duced concentrations of circulating leptin. Here, female Stat3-
CAgRP mice exhibited the clearest reduction (40%), reflecting
the most pronounced reduction in fat mass of this group of
mice (Figure 2F).
To investigate whether the reduction in white adipose tissue
(WAT) mass in Stat3-CAgRP mice was accompanied by altered
adipocyte characteristics, we next assessed the histomorphol-
ogy of WAT in control and Stat3-CAgRP mice. Histological analy-
sis revealed a significant reduction of adipocyte size in Stat3-
CAgRP mice compared to control mice (Figure 2G). Quantitative
assessment of adipocyte size revealed a striking 70% reduction
in the mean adipocyte size in Stat3-CAgRP mice compared to
control mice under NCD conditions (Figure 2H). Similarly,
mean adipocyte size in Stat3-CAgRP mice exposed to HFD was
reduced by 80% compared to control mice fed the same diet
(Figure 2H). Analysis of adipocyte size distribution revealed an
increased number of small adipocytes and an absence of large
adipocytes in epigonadal WAT of Stat3-CAgRP mice under both
NCD and HFD conditions (Figure S2).
To analyze the onset and development of reduced adiposity,
we determined body fat content of Stat3-CAgRP mice at different
postnatal ages. While at the age of 3 weeks, there was no differ-
ence in body fat content between control and Stat3-CAgRP mice,
13- and 20-week-old Stat3-CAgRP mice on either NCD or HFD
showed 20%–40% reduced fat content (Figure 2I). Thus, lean-
ness in Stat3-CAgRP mice develops progressively after the post-
weaning age.
Taken together, these results indicate that constitutive activa-
tion of Stat3-dependent signaling in AgRP-expressing neurons
results in a reduction of body weight and fat mass.
Improved Glucose Metabolism in Stat3-CAgRP Mice
To analyze whether leanness in Stat3-CAgRP mice leads to alter-
ations in glucose metabolism, we next directly compared glu-
cose metabolism in control and Stat3-CAgRP mice. Stat3-CAgRP
mice exhibited normal blood glucose levels under both NCD
and HFD conditions (Figure S3A). A 16 hr fast resulted in signif-
icantly lower blood glucose concentrations in female and male
Stat3-CAgRP mice on HFD compared to controls, whereas
Stat3-CAgRP mice on NCD displayed normal blood glucose con-
centrations upon fasting (Figure S3A). Glucose tolerance tests
revealed that both female and male Stat3-CAgRP mice on HFD
were significantly more glucose tolerant than controls, while
Stat3-CAgRP mice on NCD exhibited unaltered glucose tolerance
(Figure S3B). Consistent with these findings, serum insulin con-
centrations of Stat3-CAgRP mice on NCD were not altered,
but serum levels of Stat3-CAgRP mice on HFD were slightlydecreased (Figure S3C). This increased glucose tolerance dis-
played by Stat3-CAgRP mice compared to controls indicates
that the leanness present in these mice results in improved
glucose metabolism.
Stat3 Activation in AgRP Neurons
Increases Energy Expenditure
To further analyze the mechanisms resulting in the leanness of
Stat3-CAgRP mice, we measured food intake and energy expen-
diture in these mice. Stat3-CAgRP mice showed food intake com-
parable to control mice despite their lower body and fat mass
(Figure 3A). This unaltered food intake was consistent during
development under both NCD and HFD conditions. When we
corrected food intake for lean mass, Stat3-CAgRP mice exhibited
a slight postpubertal hyperphagia (Figure S4). Therefore, the
decreased body and fat mass in Stat3-CAgRP mice is clearly
not the result of reduced caloric intake.
However, indirect calorimetric analysis revealed a dramatic
increase in oxygen consumption in Stat3-CAgRP mice compared
to control mice (Figure 3B). While 5-week-old Stat3-CAgRP mice
showed only a slight tendency toward higher oxygen consump-
tion compared to control animals, 9-week-old mice consumed
15%–20% more oxygen during both day and night phases. Ox-
ygen consumption in older Stat3-CAgRP mice at the age of 13
weeks was increased by more than 30% during the light phase
and more than 40% during the dark phase (Figure 3B). Taken
together, these data indicate that the leanness in Stat3-CAgRP
mice is the consequence of increased energy expenditure.
Unaltered AgRP Expression in Stat3-CAgRP Mice
We next determined the expression of different neuropeptides
critically involved in the regulation of energy homeostasis, partic-
ularly AgRP. Basal and fasting-induced AgRP expression in
Stat3-CAgRP mice on NCD were indistinguishable from controls
(Figure 4A). After 48 hr of fasting, AgRP mRNA levels were
equally elevated in control and Stat3-CAgRP mice. This confirms
that activation of Stat3 does not alter fasting-induced transcrip-
tion of AgRP mRNA (Kaelin et al., 2006). Analysis of NPY and
POMC mRNA expression revealed no difference between
Stat3-CAgRP mice and controls (Figure 4B).
As leanness in Stat3-CAgRP mice is a consequence of in-
creased energy expenditure, we next analyzed UCP mRNA
expression in WAT, skeletal muscle, and brown adipose tissue
(BAT) of control and Stat3-CAgRP mice exposed to HFD condi-
tions. This analysis revealed no difference in UCPmRNA expres-
sion (Figures 4C–4E). Since energy expenditure is also controlled
by thyroid function, we tested free tri-iodothyronine levels as an
indicator of thyroid function in the different groups of mice. Se-
rum free tri-iodothyronine levels were not altered in Stat3-CAgRP
mice under either NCD or HFD conditions (Figure 4F). Thus, in-
creased energy expenditure occurs in the presence of unaltered
uncoupling protein expression and normal thyroid function.
Stat3-CAgRP Mice Exhibit Increased Locomotor Activity
To investigate whether the leanness and the increase in energy
expenditure of Stat3-CAgRP mice resulted from enhanced loco-
motor activity, we analyzed basal locomotor activity of control
and Stat3-CAgRP mice. At 5 weeks of age, Stat3-CAgRP mice ex-
hibited a weak tendency toward higher locomotor activity thanCell Metabolism 7, 236–248, March 2008 ª2008 Elsevier Inc. 239
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Stat3 Activation in AgRP NeuronsFigure 2. Reduced Body Weight and Adiposity of Stat3-CAgRP Mice
(A) Average body weight of female control (-) and Stat3-CAgRP (,) mice on NCD and female control (C) and Stat3-CAgRP mice (B) on HFD (n = 21–53 per
genotype and condition).
(B) Average body weight of male control (-) and Stat3-CAgRP (,) mice on NCD andmale control (C) and Stat3-CAgRP mice (B) on HFD (n = 18–41 per genotype
and condition).
(C) Photographs of representative epigonadal fat pads in situ of male control and Stat3-CAgRP mice on NCD and female control and Stat3-CAgRP mice on HFD at
the age of 20 weeks.
(D) Epigonadal fat-pad weights of control (black bars) and Stat3-CAgRP (white bars) mice on NCD and on HFD at 20 weeks of age (n = 5–16 per genotype and
condition).
(E) Average body fat content of control (black bars) and Stat3-CAgRP (white bars) mice on NCD and on HFD at 20 weeks of age as measured by nuclear magnetic
resonance (n = 7–11 per genotype and condition).
(F) Serum leptin concentrations of control (black bars) and Stat3-CAgRP (white bars) mice on NCD and on HFD at 20 weeks of age (n = 13–20 per genotype and
condition).
(G) Representative hematoxylin and eosin-stained epigonadal fat-pad sections frommale control and Stat3-CAgRP mice on NCD and on HFD at 20 weeks of age.
Scale bar = 500 mm (1003 magnification).240 Cell Metabolism 7, 236–248, March 2008 ª2008 Elsevier Inc.
Cell Metabolism
Stat3 Activation in AgRP NeuronsFigure 3. Unaltered Food Intake and Increased Basal Metabolic Rate in Stat3-CAgRP Mice
(A) Daily food intake of control (black bars) and Stat3-CAgRP (white bars) mice on NCD and on HFD at the indicated ages (n = 6–15 per genotype and condition).
(B) Oxygen consumption of control (-) and Stat3-CAgRP (,) mice on HFD over time, and mean oxygen consumption of control (black bars) and Stat3-CAgRP
(white bars) mice at the indicated ages (n = 6 per genotype).
All displayed values are means ± SEM. *p% 0.05, **p% 0.01, ***p% 0.001 versus control.their control littermates, consistent with the unaltered energy
expenditure (Figure 5A). At 9 weeks of age, however, Stat3-
CAgRP mice exhibited a dramatic increase in basal locomotor
activity, by 40% during the light phase and 60% during the dark
phase compared to control mice, correlating with the observed
significant increase in energy expenditure at this age (Figure 5A).
Stat3-CAgRP mice exhibited the highest locomotor activity at the
beginning of the dark phase, where they weremore than twice as
active as their littermate controls (Figure 5A).Fasting increases light- and dark-phase locomotor activity
(Overton andWilliams, 2004;Williams et al., 2003), and both con-
trol and Stat3-CAgRP mice showed increased activity upon food
deprivation in the light and dark phases (Figure 5B). Again, the
fasting-induced locomotor activity of Stat3-CAgRP mice was
significantly higher than that of control animals (Figure 5B). To
further address whether activating Stat3 signaling in AgRP
neurons specifically accounted for the observed increase in
locomotor activity, we also generated mice expressing Stat3-C(H) Mean adipocyte size of epigonadal fat in control (black bars) and Stat3-CAgRP (white bars) mice on NCD and on HFD at 20 weeks of age (n = 4–5 mice per
condition, 28–49 adipocytes per mouse).
(I) Average body fat content of control (black bars) and Stat3-CAgRP (white bars) mice on NCD and on HFD at the indicated ages asmeasured by nuclear magnetic
resonance (n = 7–11 per genotype and condition).
All displayed values are means ± SEM. *p% 0.05, **p% 0.01, ***p% 0.001 versus control.Cell Metabolism 7, 236–248, March 2008 ª2008 Elsevier Inc. 241
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Stat3 Activation in AgRP NeuronsFigure 4. Unaltered Hypothalamic Neuropeptide Expression, UCP Expression, and Thyroid Function of Stat3-CAgRP Mice
(A) Fasting-induced AgRP expression in NCD-fed control (black bars) and Stat3-CAgRP (white bars) mice (n = 7–9 per genotype).
(B) Hypothalamic expression of NPY and POMC in NCD-fed control (black bars) and Stat3-CAgRP (white bars) mice (n = 7 per genotype).
(C) Expression of UCP2 and UCP3 in white adipose tissue (WAT) of HFD-fed control (black bars) and Stat3-CAgRP (white bars) mice (n = 6–9 per genotype).
(D) Expression of UCP2 and UCP3 in skeletal muscle of HFD-fed control (black bars) and Stat3-CAgRP (white bars) mice (n = 5–7 per genotype).
(E) Expression of UCP1 in brown adipose tissue (BAT) of HFD-fed control (black bars) and Stat3-CAgRP (white bars) mice (n = 6–9 per genotype).
(F) Serum free tri-iodothyronine (fT3) levels in control (black bars) and Stat3-CAgRP (white bars) mice on NCD and on HFD (n = 13–20 per genotype and condition).
All experiments were performed on tissues obtained frommice of the indicated genotype and gender at 20 weeks of age. All displayed values are means ± SEM.
*p% 0.05, **p% 0.01, ***p% 0.001 versus control.specifically in neighboring POMC neurons in the ARC of the
hypothalamus (M.B.E., A.M., and J.C.B., unpublished data). In
contrast to Stat3-CAgRP mice, Stat3-CPOMC mice exhibited unal-
tered locomotor activity and energy expenditure at an age where
both parameters were altered in Stat3-CAgRP mice, further sup-
porting the specificity of the observed phenotype in Stat3-CAgRP
mice (Figures S5A and S5B). Thus, we conclude that the lean-
ness and increased energy expenditure in Stat3-CAgRP mice
are the result of markedly increased locomotor activity in these
mice.
To gain insight into the mechanism underlying the increase in
locomotor activity of Stat3-CAgRP mice, wemeasured circulating
plasma catecholamine concentrations in control and Stat3-
CAgRP mice. Both epinephrine and norepinephrine concentra-
tions were lower in Stat3-CAgRP mice compared to control mice
under NCD conditions, whereas only norepinephrine concentra-
tions tended to be lower in these animals under HFD conditions
(Figures 6A and 6B). Thus, we conclude that increased locomo-
tor activity does not result from increased peripheral sympathetic
nerve activity.
Next we examined catecholamine and serotonin content in
different brain areas critically implicated in the regulation of loco-
motor activity, but we could not detect any significant differ-
ences between control and Stat3-CAgRP mice (Figures 6C–6F).
Nevertheless, Stat3-CAgRP mice exhibited a tendency toward
higher dopamine and serotonin levels in the striatum and frontal
cortex (Figures 6E and 6F; Figure S6).242 Cell Metabolism 7, 236–248, March 2008 ª2008 Elsevier Inc.Furthermore, we determined hypothalamic expression of
hypocretin and melanin-concentrating hormone (MCH) since
both of these neuropeptides are involved in the regulation of
locomotor activity and since AgRP neurons have been demon-
strated to project into the lateral hypothalamus, where hypocre-
tin- and MCH-expressing neurons reside (Broberger et al., 1998;
Hagan et al., 1999). Stat3-CAgRP mice showed no difference in
the expression of either hypocretin or MCH compared to control
animals (Figures 6G and 6H).
DISCUSSION
Obesity and associated insulin-resistant type 2 diabetes repre-
sent a steadily growing health burden in industrialized societies.
To prevent or treat these disease entities, it is critical to define
the physiological principles for precise regulation of energy
homeostasis. Several experiments over the last decade have
highlighted the pivotal role of leptin in normal body weight and
glucose homeostasis in both rodents and humans. Analyses of
brain-restricted leptin receptor knockout mice as well as leptin
receptor knockout mice with reconstitution of leptin receptor ex-
pression selectively in thebrain haveprovidedclear evidence that
leptin action in the central nervous system (CNS) accounts for
most, if not all, of leptin’s effects on energy and glucose homeo-
stasis (Cohen et al., 2001; Kowalski et al., 2001). However, the
leptin receptor is expressed in several CNS sites, and recent
experiments with mice lacking the receptor in specific neuronal
Cell Metabolism
Stat3 Activation in AgRP NeuronsFigure 5. Increased Basal and Fasting-Induced Locomotor Activity of Stat3-CAgRP Mice
(A) Basal locomotor activity of HFD-fed control (-) and Stat3-CAgRP (,) mice over time, and mean basal locomotor activity of control (black bars) and
Stat3-CAgRP (white bars) mice at the indicated ages (n = 7–8 per genotype).
(B) Fasting-induced locomotor activity of HFD-fed control (-) and Stat3-CAgRP (,) mice over time, andmean fasting-induced locomotor activity of control (black
bars) and Stat3-CAgRP (white bars) mice at 9 weeks of age (n = 7–8 per genotype).
All displayed values are means ± SEM. *p% 0.05, **p% 0.01, ***p% 0.001 versus control.subpopulations such as POMC neurons and neurons of the ven-
tromedial hypothalamus have begun to shed light on the relative
contribution of leptin signaling in individual CNS sites with re-
spect to the regulation of energy and glucose homeostasis
(Balthasar et al., 2004; Dhillon et al., 2006).Moreover, pharmaco-
logical studies showing that melanocortin-4 receptor (MC4R) an-
tagonists can blunt the acute anorectic effect of centrally applied
leptin have underlined the importance of the melanocortin sys-
tem in regulating leptin’s effect at least concerning the regulation
of food intake (da Silva et al., 2004). Thus, leptin action in POMC-
andAgRP-expressing neuronsplaysakey role in the regulation of
energy homeostasis.
Much of the research on intracellular signaling pathways acti-
vated by the leptin receptor and their relative contributions
to mediating different aspects of leptin action has focused on
the leptin-stimulated activation of the Stat3 signaling pathway.
Indeed, mice with mutated leptin receptors that do not bind
Stat3, as well as mice lacking Stat3 specifically in the brain, de-
velop an obese phenotype (Bates et al., 2003; Gao et al., 2004),
underlining the essential role of leptin-stimulated Stat3 activation
in the regulation of energy homeostasis. Nevertheless, the role of
leptin-stimulated activation of Stat3 in distinct leptin-responsive
neurons and particularly in the regulation of AgRP expression
has remained a controversial issue. Mice with a point mutation
of the Stat3 binding site on the leptin receptor and panneuronal
Stat3 knockout mice exhibit increased AgRP mRNA expression
(Bates et al., 2003; Gao et al., 2004), but these experiments donot answer the question of whether Stat3 activation is directly
involved in AgRP regulation. Alternatively, increased AgRP ex-
pression may occur secondarily to other disturbed signaling
events. Moreover, while overexpression of Stat3 in cultured cells
inhibits AgRP transcription in reporter gene assays (Kitamura
et al., 2006), AgRP neuron-restricted Stat3 gene inactivation
has no effect on AgRP expression in vivo (Kaelin et al., 2006).
Consistent with the data on AgRP neuron-specific Stat3 knock-
out mice, the Stat3-CAgRP mice with AgRP neuron-restricted
constitutive activation of Stat3 analyzed in this study exhibited
unaltered expression of AgRP, thus providing evidence that nei-
ther the lack of Stat3 nor the constitutive activation of Stat3 leads
to dysregulated AgRP expression in vivo. These data are consis-
tent with a recent report indicating that PI3 kinase-mediated in-
hibition of FOXO1 accounts for leptin’s and insulin’s ability to
regulate AgRP expression (Gropp et al., 2005; Kitamura et al.,
2006).
Nevertheless, the leanness of Stat3-CAgRP mice on a normal
chow diet and their relative resistance to the development of
high-fat-diet-induced obesity underline the critical role of Stat3
activation in AgRP neurons for maintaining energy balance.
Strikingly, the leanness of Stat3-CAgRP mice is not a conse-
quence of reduced food intake but occurs as a consequence
of increased locomotor activity and energy expenditure. Hence,
differential pathways activated by leptin within AgRP neurons
apparently target different biological responses to result in neg-
ative energy balance, i.e., leptin-stimulated PI3 kinase activationCell Metabolism 7, 236–248, March 2008 ª2008 Elsevier Inc. 243
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Stat3 Activation in AgRP NeuronsFigure 6. Plasma and Brain Monoamines and Hypothalamic Hypocretin and MCH Expression of Stat3-CAgRP Mice
(A) Plasma epinephrine concentration of male control (black bars) and Stat3-CAgRP (white bars) mice on NCD and on HFD at 16–18 weeks of age (n = 8–14 per
genotype and condition).
(B) Plasma norepinephrine concentration of male control (black bars) and Stat3-CAgRP (white bars) mice on NCD and on HFD at 16–18 weeks of age (n = 8–14 per
genotype and condition).
(C) Epinephrine concentration in different brain areas of male control (black bars) and Stat3-CAgRP (white bars) mice on HFD at 16–20 weeks of age (n = 7–10 per
genotype).
(D) Norepinephrine concentration in different brain areas of male control (black bars) and Stat3-CAgRP (white bars) mice on HFD at 16–20 weeks of age (n = 7–10
per genotype).
(E) Dopamine concentration in different brain areas of male control (black bars) and Stat3-CAgRP (white bars) mice on HFD at 16–20 weeks of age (n = 7–10 per
genotype).
(F) Serotonin concentration in different brain areas of male control (black bars) and Stat3-CAgRP (white bars) mice on HFD at 16–20 weeks of age (n = 7–10 per
genotype).
(G) Hypothalamic expression of hypocretin in control (black bars) and Stat3-CAgRP (white bars) mice on NCD (n = 7 per genotype).
(H) Hypothalamic expression of melanin-concentrating hormone (MCH) in control (black bars) and Stat3-CAgRP (white bars) mice on NCD (n = 7 per genotype).
Ht, hypothalamus; VTA, ventral tegmental area; FrA, frontal association cortex; CPu, caudate putamen (striatum). All displayed values are means ± SEM.
*p% 0.05, **p% 0.01, ***p% 0.001 versus control.via inhibition of FOXO activity inhibits AgRP mRNA expression,
thus regulating food intake (Kitamura et al., 2006). These data
are consistent with the hypophagia observed in mice with acute
ablation of AgRP/NPY-expressing neurons and also with the
late-onset hypophagia observed in AgRP knockout mice (Gropp
et al., 2005; Luquet et al., 2005; Wortley et al., 2005). The present
study reveals a critical role for Stat3 activation in the stimulation
of locomotor activity and energy expenditure independent of
the direct regulation of food intake or AgRP mRNA expression
in AgRP neurons. Thus, our experiments reveal an important
mechanistic insight into the role of Stat3 specifically in AgRP
neurons with respect to energy homeostasis. Stat3-dependent
regulation of locomotor activity via AgRP neurons is consistent
with the recent observation that unilateral restoration of leptin
signaling in leptin receptor-deficient mice specifically in the
ARC restores impaired locomotor activity to normal, which pro-
vides direct evidence for important regulators of locomotor ac-
tivity in this neuronal site (Coppari et al., 2005). In our current
study, we extend this notion by two important findings. First,244 Cell Metabolism 7, 236–248, March 2008 ª2008 Elsevier Inc.we directly define the neuronal population responsible for regu-
lating locomotor activity within the ARC as the AgRP-expressing
neurons. Second, we demonstrate that Stat3 activation in this
cell type mediates the regulation of locomotor activity, consis-
tent with the reduced locomotor activity observed in mice with
a mutation of the Stat3 binding site of the leptin receptor (Bates
et al., 2004).
Taken together, the results of the present study suggest a
model in which leptin-stimulated Stat3 activation in AgRP neu-
rons directly regulates locomotor activity independently of its
regulation of AgRP mRNA expression. Dopaminergic neurons
represent classical regulatory centers for locomotor behavior
(Zhou and Palmiter, 1995), and AgRP neurons may regulate the
dopaminergic system via projections to melanocortin-express-
ing neurons in the lateral hypothalamus. Nevertheless, the ab-
sence of detectable changes in MCH and hypocretin expression
indicates the existence of alternative pathways by which AgRP
neurons control locomotor activity. Although the literature is
sparse on how ARC neurons integrate the regulation of
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Stat3 Activation in AgRP Neuronslocomotor behavior, some studies indicate a role for MSH and
MC4R signaling in the control of striatal dopamine regulation
and locomotor activity; these findings are consistent with the
trend toward increased dopamine concentrations in this region
in Stat3-CAgRP mice (Hsu et al., 2005; Sanchez et al., 2001; San-
dyk, 1990; Singhal and Rastogi, 1982). Clearly, future studies are
needed to further define the anatomical interaction of AgRP neu-
rons with other known centers that control locomotor activity.
Nevertheless, Stat3-dependent regulation of locomotor activity
provides a promising new target for the development of novel
therapeutic approaches to the current obesity epidemic.
EXPERIMENTAL PROCEDURES
Animal Care
All animal care was within University of Cologne institutional animal care com-
mittee guidelines. All procedures were approved by local government author-
ities (Bezirksregierung Ko¨ln) and were in accordance with NIH guidelines. Mice
were housed in groups of 3–5 or individually if required for experiments as
indicated. Animals weremaintained at 22C–24Cwith a 12 hr light/dark cycle,
with lights on at 7 a.m. Mice were fed either normal chow diet (Teklad Global
Rodent #T.2018.R12, Harlan) containing 53.5% carbohydrates, 18.5% pro-
tein, and 5.5% fat (12% of calories from fat) or a high-fat diet (#C1057, Altro-
min) containing 32.7% carbohydrates, 20% protein, and 35.5% fat (55.2%
of calories from fat). Animals were given ad libitum access to water, and
food was withdrawn only if required for an experiment. Body weight was
measured once a week.
Generation of Mice Expressing Constitutively
Active Stat3 in AgRP Neurons
Tissue-specific Stat3-C mice were generated by transfecting Bruce4 ES cells
with a vector targeting Stat3-C cDNA and a 50 loxP-flanked NeoR stop cassette
into the Rosa26 housekeeping gene. The modified Rosa26 vector (Sasaki
et al., 2006) contained FLAG-tagged Stat3-C cDNA (kindly provided by J. Dar-
nell, The Rockefeller University) together with a 30 FRT-flanked IRES-eGFP
cloned downstream of the floxed NeoR stop cassette and was fully sequenced
and linearized before being electroporated into the C57BL/6-derived ES cells.
Homologous recombinant ES cells were identified by Southern blot analysis
and injected into blastocysts, and high-grade chimeric mice were bred for
germline transmission of the transgene.
Breeding colonies were maintained by mating Stat3-Cstoplox/lox mice with
AgRPCre mice. Only animals from the same mixed-background strain gener-
ation were compared. Mice were genotyped by PCR using genomic DNA iso-
lated from tail tips. AgRPCre primers used were AgRPCre 50, 50-CCCTAAGGA
TGAGGAGAGAC-30; Cre-intern-rev-30, 50-ATGTTTAGCTGGCCCAAATGT-30;
and AgRP-Intron, 50-ACTTGGTGCATGGTGGGTGT-30. POMCCre primers
used were POMCCre 50, 50-TGGCTCAATGTCCTTCTTGG-30; Cre-intern-rev-
30, 50-GAGATATCTTTAACCCTGATC-30; and POMC-Intron, 50-CACATAAG
CTGCATCGTTAAG-30. Stat3-C primers used were Typ_forward, 50-AAAG
TCGCTCTGAGTTGTTATC-30; NeoRT, 50-GCATCGCCTTCTATCGCCT-30;
and Typ_reverse, 50-GATATGAAGTACTGGGCTCTT-30. Germline deletion
was detected using the NeoRT primer located in the floxed neomycin cassette.
Animals with germline deletion (approximately 1%) were excluded from the
experiments.
RT-PCR
RNA isolation was performed using the RNeasy system (QIAGEN) according to
the manufacturer’s instructions. Total RNA was treated with RNase-free
DNase (Promega), and 200 ng of RNAwas reverse transcribed with EuroScript
reverse transcriptase (Eurogentec). Stat3-C, endogenous Stat3, and GAPDH
were amplified using the following specific primers. Stat3-C primers:
Rosa512, 50-GCCGTTCTGTGAGACAG-30; 3StatRT, 50-AGGACATTGGACTC
TTGCAG-30. Endogenous Stat primers: 5StatRT, 50-CAGTCGGGCCTCAGCC
C30; 3StatRT, 50-AGGACATTGGACTCTTGCAG-30. GAPDH primers: GAPDH
50, 50-ACCACAGTCCATGCCATCAC-30; GAPDH 30, 50-TCCACCACCCTGTTG
CTGTA-30.Analysis of RNA Expression
mRNA expression was analyzed using quantitative RT-PCR. cDNA was ob-
tained from hypothalamic tissue, WAT, BAT, and skeletal muscle as described
above and amplified using TaqMan Universal PCR Master Mix, No AmpErase
UNG with TaqMan Assay-on-Demand kits (Applied Biosystems), with the ex-
ception of POMC mRNA, which was detected using customized primers for
POMC: sense, 50-GACACGTGGAAGATGCCGAG-30; antisense, 50-CAGCGA
GAGGTCGAGTTTGC-30; probe sequence, 50-FAM-CAACCTGCTGGCTTGCA
TCCGG-TAMRA-30. Standard curves were used based on hypothalamic
cDNA, WAT, BAT, and skeletal muscle cDNA. Relative expression of samples
was adjusted for total RNA content by hypoxanthine guanine phosphoribosyl-
transferase 1 (Hprt) RNA quantitative PCR. Calculations were performed by a
comparative method (2-ddCt). Quantitative PCR was performed on an ABI
Prism 7700 sequence detector (Applied Biosystems). Assays were linear
over at least four orders of magnitude.
Intracerebroventricular BrdU Injection
Detection of 5-bromodeoxyuridine (BrdU) incorporation was performed on in-
tracerebroventricularly BrdU-injected mice as described previously (Kokoeva
et al., 2005). Briefly, 20-week-old mice were anesthetized with Avertin (2,2,2-
tribromoethanol, 240 mg/kg, Sigma) and placed into a stereotactic device.
A sterile cannula (Brain Infusion Kit 3, Alzet) was implanted into the right lateral
brain ventricle (0.2 mm posterior and 1 mm lateral relative to bregma; 2.3 mm
below the surface of the skull) and connected to an osmotic minipump (Alzet
model 1002, flow rate 0.25 ml/hr) filled with 2 mg/ml BrdU (Sigma) in artificial
cerebrospinal fluid. The mice were infused with 12 mg BrdU per day for 7 days.
Immunohistochemistry
AgRPCre mice were mated with RosaArte1 reporter mice (Seibler et al., 2003).
Mice double positive for AgRPCre and LacZ under Avertin anesthesia were
transcardially perfused with saline followed by 4% paraformaldehyde (PFA)
in 0.1 M phosphate-buffered saline (PBS; pH 7.4). The brains were dissected
and frozen in Jung tissue freezing medium (Leica Microsystems) after postfix-
ation in 4% PFA at 4C overnight and soaking in 20% sucrose for 6 hr.
Free-floating coronal sections (25 mm thick) were cut through the ARC using
a freezing microtome (Leica Microsystems). The sections were then washed
extensively in PBS to remove cryoprotectant and treated with 0.3% H2O2 in
PBS for 20min to quench endogenous peroxidase activity. Following pretreat-
ments, the sections were stained using a Renaissance Tyramide Signal Ampli-
fication kit (PerkinElmer) according to the manufacturer’s guidelines (primary
antibody, rabbit anti-lacZ [Cappel]; secondary antibody, peroxidase-labeled
goat anti-rabbit [Vector Laboratories]).
Combined In Situ Hybridization and Immunohistochemistry
For NPY probe synthesis, a PCR fragment was amplified frommouse hypotha-
lamic cDNA using primers containing a T7 promoter sequence and NPY-spe-
cific sequences (50-ATGCTAGGTAACAAGCGAATGG-30; 50-TAATACGACTCA
CTATAGGGTCACCACATGGAAGGGTCTTC-30). The DNA fragment was tran-
scribed into digoxigenin-labeled RNA using the DIG RNA Labeling Kit (Roche).
For NPY in situ hybridization, control and Stat3-CAgRP mice were fasted for
48 hr, anesthetized, and transcardially perfused as described above. After dis-
section, the brains were postfixed in 4% PFA for 4 hr and soaked in 20% su-
crose overnight at 4C. Coronal sections (8 mm thick) containing the ARC were
dried at room temperature, washed with PBS, and treated with proteinase K
(0.25 mg/ml) for 10 min at 37C. The sections were rinsed with glycine (2 mg/
ml), placed into 4% PFA, washed with PBS, and then washed with 23 SSC.
Prehybridization was carried out for 5 hr at 55C in prehybridization buffer con-
taining 50% formamide, 53 SSC, 13 Denhardt’s solution, and 0.1% Tween
20. Hybridization was performed at 55C overnight with 2 ng/ml digoxigenin-la-
beled RNA probe. After washing with 23 SSC, the sections were RNase
digested for 1 hr at 37C and afterwards washed with 0.13 SSC for 1 hr at
55C, cooled to room temperature, and treated with hydrogen peroxide
(1%) for 1 hr. The sections were blocked for 1 hr and incubated with anti-digox-
igenin antibody coupled to alkaline phosphatase (Roche) for 1 hr. After wash-
ing, NPY in situ hybridization was detected using the Vector Blue Alkaline
Phosphatase Substrate Kit III (Vector Laboratories). To determine mean NPY
neuron size, AxioVision 4.2 software (Carl Zeiss MicroImaging) was used.Cell Metabolism 7, 236–248, March 2008 ª2008 Elsevier Inc. 245
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Stat3 antibody (Santa Cruz Biotechnology, Inc.) together with anti-digoxigenin
antibody. Stat3 immunostaining was developed prior to the detection of alka-
line phosphatase using a Renaissance Tyramide Signal Amplification kit as
described above (secondary antibody, peroxidase-labeled goat anti-rabbit
[Vector Laboratories]).
For combined BrdU immunohistochemistry, NPY-stained sections were
treated with HCl (2 N) for 1 hr and incubated with anti-BrdU antibody (Accurate
Chemical & Scientific) overnight at 4C after blocking. BrdU immunostaining
was visualized using a Renaissance Tyramide Signal Amplification kit as
described above (secondary antibody, peroxidase-labeled goat anti-rat
[Jackson ImmunoResearch Laboratories, Inc.]).
Body Composition
Body fat content was measured in vivo by nuclear magnetic resonance using
a minispec mq 7.5 (Bruker Optics).
Histomorphology
Dissected WAT samples were incubated in fixation solution containing 4%
PFA at 4C overnight and embedded in paraffin according to a standard pro-
tocol (Plum et al., 2006). Sections (7 mm) were mounted onto gelatin-coated
slides and stained with hematoxylin and eosin (H&E; Sigma) after deparaffini-
zation as described previously (Plum et al., 2006). Determination of mean
adipocyte size and adipocyte size distribution was carried out in H&E-stained
tissues using AxioVision 4.2 software (Carl Zeiss MicroImaging).
Analytical Procedures
Blood glucose values were determined from whole venous blood using a
GlucoMen Glyco´ automatic glucose monitor (A. Menarini Diagnostics). Serum
insulin, leptin, and free tri-iodothyronine (fT3) levels as well as plasma cate-
cholamine concentrations were measured by ELISA according to manufac-
turer guidelines (Mouse/Rat Insulin ELISA and Mouse Leptin ELISA, Crystal
Chem; fT3 ELISA, Alpha Diagnostics International. Inc.; CatCombi ELISA, IBL).
Brain catecholamine and serotonin concentrations were measured by
ELISA (TriCat ELISA and Serotonin ELISA, DRG Instruments). Brain areas of
interest (hypothalamus, ventral tegmental area, frontal association cortex,
and striatum)were dissectedwith the aid of amouse brain atlas using a coronal
acrylic brainmatrix (Braintree Scientific, Inc.). Brain tissue was homogenized in
0.05 N HCl. After centrifugation, the supernatant was used to determine cate-
cholamine concentrations according to the manufacturer’s guidelines. For
determination of serotonin concentrations, ascorbic acid was added to the
supernatant to a final concentration of 1 mg/ml, and serotonin concentrations
were measured according to the manufacturer’s guidelines.
Food Intake, Indirect Calorimetry and Physical Activity
Food intake was measured over a 2 week period, during which mice were
housed individually in regular cages using food racks. To minimize handling
of the animals, food racks were weighed once a week, and daily food intake
was calculated as the average daily intake of chow within the time stated.
Indirect calorimetry was measured in a calorimetry module (CaloSys v2.1,
TSE Systems). After 2 hr of acclimatization, parameters of indirect calorimetry
were measured for at least 48 hr. For measurement of physical activity, trans-
mitters (PDT-4000 E-Mitter, VitalView Data Acquisition System 4.1;Mini Mitter)
were implanted into the peritoneal cavity of anesthetized mice. After 7 days,
mice that reached at least 90% of their preoperative body weight were placed
into 3.0 l chambers of a Comprehensive Laboratory Animal Monitoring System
(CLAMS, Oxymax Windows v4.00; Columbus Instruments). For measurement
of basal locomotor activity, food and water were provided ad libitum. Mice
were allowed to acclimatize in the chambers for 2 hr, and physical activity
was measured for at least the following 48 hr. For measurement of fasting-in-
duced locomotor activity, food waswithdrawn and activity wasmeasured over
the following 24 hr.
Glucose Tolerance Tests
Glucose tolerance tests were performed on animals after a 16 hr fast. After de-
termination of fasted blood glucose levels, each animal received an intraperi-
toneal injection of 20% glucose (10 ml/kg body weight) (DeltaSelect). Blood
glucose levels were detected 15, 30, 60, and 120 min after glucose injection.246 Cell Metabolism 7, 236–248, March 2008 ª2008 Elsevier Inc.Statistical Methods
All data were normally distributed. Data were analyzed for statistical signifi-
cance by two-tailed unpaired Student’s t test. Prior to performing t tests,
homogeneity of variances was tested, and homoscedastic or heteroscedastic
t test was performed accordingly.
All displayed values are means ± SEM. *p% 0.05, **p% 0.01, ***p% 0.001
versus control.
SUPPLEMENTAL DATA
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